| abstract |
This disclosure An isolated immunity selected from the group consisting of an isolated immunogenic Streptococcus pneumoniae PcpA polypeptide and at least one additional antigen (eg, a polyhistidine triad family of proteins (eg, PhtD)) Relates to immunogenic compositions comprising Streptococcus pneumoniae polypeptides) and methods of using these compositions for preventing and treating diseases caused by Streptococcus pneumoniae. |